RANDY WAYNE LASUT
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NEW PARIS, PA NPI 1063282994
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family PA Otsuka America Pharmaceutical, Inc. All categories
General Payments — all program years on this page
$884.03
- Category: General Payments
- Program years: PY2024
- Record count: 53
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $884.03 across 53 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $884.03 | 53 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $76.57 | 4 |
| Astellas Pharma US Inc | $61.49 | 3 |
| Axsome Therapeutics, Inc. | $61.19 | 3 |
| Lilly USA, LLC | $59.06 | 4 |
| GlaxoSmithKline, LLC. | $55.78 | 4 |
| Exact Sciences Corporation | $52.75 | 3 |
| Acerta Pharma LLC | $48.64 | 3 |
| PFIZER INC. | $45.25 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $42.05 | 3 |
| Lundbeck LLC | $38.93 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $36.74 | 2 |
| DEXCOM, INC. | $32.99 | 2 |
| ABBVIE INC. | $31.99 | 2 |
| Mylan Specialty L.P. | $31.98 | 2 |
| Novo Nordisk AS | $30.66 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $28.69 | 2 |
| Ardelyx, Inc. | $23.31 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.65 | 1 |
| Janssen Pharmaceuticals, Inc | $17.51 | 1 |
| UCB, Inc. | $17.41 | 1 |
| Corcept Therapeutics | $16.26 | 1 |
| SANOFI PASTEUR INC. | $14.70 | 1 |
| Xeris Pharmaceuticals, Inc. | $14.25 | 1 |
| Phathom Pharmaceuticals, Inc. | $13.73 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $13.45 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $884.03 | 53 |
Records — PY2024 (53)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.